ImmunoPrecise Antibodies (IPA) Earnings Date, Estimates & Call Transcripts $0.44 +0.01 (+2.55%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$0.40 -0.04 (-8.65%) As of 04/17/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmunoPrecise Antibodies Earnings Summary Latest Q3 Earnings DateMar. 28EstimatedConsensus EPS (Mar. 28) -$0.06 Actual EPS (Mar. 28) -$0.06 Actual Revenue (Mar. 28) $4.23MImmunoPrecise Antibodies issued Q3 2025 earnings on March 28, 2025, reporting an EPS of -$0.06, which met analysts' consensus estimates of -$0.06. Quarterly revenue was reported to be $4.23 million, below analyst estimates of $6.59 million. With a trailing EPS of -$1.16, ImmunoPrecise Antibodies' earnings are expected to grow next year, from ($0.27) to ($0.13) per share. Q3 2025 Earnings ResourcesQ3 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Press Release (6-K)Powered by Get ImmunoPrecise Antibodies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImmunoPrecise Antibodies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIPA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IPA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ImmunoPrecise Antibodies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.09-$0.09-$0.09Q2 20251-$0.05-$0.05-$0.05Q3 20251-$0.06-$0.06-$0.06Q4 20251-$0.02-$0.02-$0.02FY 20254-$0.22-$0.22-$0.22Q1 20261-$0.03-$0.03-$0.03Q2 20261-$0.02-$0.02-$0.02Q3 20261-$0.02-$0.02-$0.02Q4 20261-$0.01-$0.01-$0.01FY 20264($0.08)($0.08)($0.08) ImmunoPrecise Antibodies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/28/2025Q3 2025-$0.06-$0.06--$0.46$6.59M$4.23M12/10/2024Q2 2025-$0.05-$0.07 -$0.02-$0.07--9/16/2024Q1 2025-$0.09-$0.11 -$0.02-$0.11$4.96M$3.85M7/29/2024Q4 2024-$0.10-$0.52 -$0.42-$0.52$4.92M$4.76M3/14/2024Q3 2024-$0.08-$0.08--$0.08$4.43M$4.60M12/14/2023Q2 2024-$0.09-$0.07+$0.02-$0.07$4.44M$4.50M9/14/2023Q1 2024-$0.17-$0.11+$0.06-$0.11$3.98M$4.26M7/10/2023Q4 2023-$0.12-$0.15 -$0.03-$0.15$4.45M$4.15M ImmunoPrecise Antibodies Earnings - Frequently Asked Questions When did ImmunoPrecise Antibodies announce their last quarterly earnings? ImmunoPrecise Antibodies (NASDAQ:IPA) last announced its quarterly earning data on Friday, March 28, 2025. Learn more on IPA's earnings history. Did ImmunoPrecise Antibodies beat their earnings estimates last quarter? In the previous quarter, ImmunoPrecise Antibodies (NASDAQ:IPA) reported ($0.06) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.06). Learn more on analysts' earnings estimate vs. IPA's actual earnings. How can I listen to ImmunoPrecise Antibodies's earnings conference call? The conference call for ImmunoPrecise Antibodies's latest earnings report can be listened to online. Listen to Conference Call How can I read ImmunoPrecise Antibodies's conference call transcript? The conference call transcript for ImmunoPrecise Antibodies's latest earnings report can be read online. Read Transcript How much revenue does ImmunoPrecise Antibodies generate each year? ImmunoPrecise Antibodies (NASDAQ:IPA) has a recorded annual revenue of $24.00 million. How much profit does ImmunoPrecise Antibodies generate each year? ImmunoPrecise Antibodies (NASDAQ:IPA) has a recorded net income of -$20.13 million. IPA has generated -$1.16 earnings per share over the last four quarters. What is ImmunoPrecise Antibodies's EPS forecast for next year? ImmunoPrecise Antibodies's earnings are expected to grow from ($0.27) per share to ($0.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies IKNA Earnings Results PYXS Earnings Results KRON Earnings Results GANX Earnings Results ONCY Earnings Results VRCA Earnings Results VNRX Earnings Results PMVP Earnings Results ICCC Earnings Results STRO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:IPA) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IPA Stock Free IPA Stock Alerts